Mikaël Pittet
"Microenvironmental coordination in human cancers"
Lecture
The recent successes of T-cell-based immunotherapies are exciting, not only because they provide effective treatment options for some cancer patients, but also because they validate the century-old notion that targeting immune cells is a relevant approach to fighting cancer. Yet, because current treatments benefit only a fraction of patients, there is an urgent need to accelerate our knowledge of anti-tumor immunity before we can fully exploit it for therapeutic purposes. Here I will discuss how myeloid cells (especially dendritic cells, neutrophils and macrophages) could be harnessed with T cells to make refractory tumors responsive to immunotherapies.
Biography
Mikaël Pittet completed his PhD thesis in immunology at the Ludwig Institute for Cancer Research and graduated from the University of Lausanne in 2001. In 2003, he moved to Boston, USA, were he pursued postdoctoral research at Massachusetts General Hospital, Dana-Farber Cancer Institute and Harvard Medical School, where he became full professor in 2019. He joined UNIGE more than two years ago, where he serves as a professor in immunology. He is also a full member of the Ludwig Cancer Center.
17 Aug 2023